"Some sectors tend to do better than others in tough times; biotechnology often surprises investors in good times and bad," suggests Brandon Clay.

In his Invest with an Edge advisory service, the growth stock advisor looks to Celgene Corporation (NASDAQ: CELG), a player in developing cancer treatments. Here's his review.

"This sometimes-perilous market niche can make or break a portfolio depending on several factors: drug pipeline, continued investment, market factors, and government approvals.

"However, despite the risks, there are times when we believe that individual biotech stocks make sense -- such as our latest recommendation for Celgene.

Cerner Corp. (NASDAQ: CERN) is a health care information technology provider, and that's a hot place to be right now.

The company reports on July 29, and earnings expectations are modest. In fact, only a third of covering analysts consider CERN a "buy," which leaves plenty of room for upgrades. The stock needs to break through potential resistance at $65, and earnings could give it that boost.

Buy CERN call options.

Next: Earnings Trade #2

Options and trading specialist Bernie Schaeffer selects stocks based on a combination of fundamental, technical and sentiment-based metrics.

His research leads to long trading positions for his Schaeffer's Master Portfolio and short trading plays for his Schaeffer's Short Selling services.

Here's a long at four of his latest trading ideas -- long positions in Netflix (NASDAQ: NFLX) and VMware (NYSE: VMW) as well as short position in Exxon Mobil (NYSE: XOM) and Apple (NASDAQ: AAPL).

This post was written by Minyanville contributor Steve Smith.

Shares of CardioNet (NASDAQ: BEAT) shares are off $0.20 to $18.60 and option volume is three times the daily average. The focus is buying in the June $17.50 put which has seen over 5,100 contracts trade, 90% of which occurred at the ask, and exceeds prior open interest of if 1,018 contracts. This new put buying is driving up implied volatility 14% to the 65% level this morning.

CREE Inc. (NASDAQ: CREE) shares are up over 12% to $31.30 after the electronics parts manufacturer pre-announced and raised guidance. Options running 3X the daily average with 85% of trades on the call side. Active strikes are the include June $30 call and July $30 calls, with latter's volume exceeding strike's of 295 exceeding prior open interest. Notable is buying in longer dated series; the Sep $30 call, Dec $35 call and Jan 2010 $30 call have all traded over 200 contracts all of which exceed their strike's prior open interest.

Patriot Coal (NYSE: PCX) is up 19 cents to $9.15 and 2,500 Jun 10 calls traded. Nearly all the volume has been done at the asking price suggesting this speculative call buying.

This post is part of a seven article report -- Food for thought: Best bets in food & beverage stocks.

"We're bullish on Juan Valdez," jests Eric Roseman, who sees an opportunity in an ETN (exchange-traded note) based on coffee prices. Here's the latest from his top-notch The Commodity Trend Alert.

"For individual commodities, supply and demand fundamentals are not ubiquitous and you really have to dig deep to find the best upside speculations. I think our time has arrived to bet on coffee.

It's been a long time since I wrote here, mainly because I've been busy busting my butt. I was up 197% in 2008, every trade detailed HERE for your learning pleasure, becoming the #1 ranked trader, out of 15,000+ on Covestor.com and growing my blog's monthly income to over $80,000 -- so yes, 2008 was a very very good year for me.

Here are five tips I'd like to pass on to help you in 2009:

1. Be honest and admit mistakes quickly. Too many people in finance these days are having problems fessing up and it not only hurts their reputation. It hurts their business and performance too!

2. Learn from your mistakes---even more important than admitting them, you must take it to the next level and learn, unlike value investors who just keep adding to their losing positions in Bank of America (NYSE: BAC), General Electric Co. (NYSE: GE) and Goldman Sachs Group (NYSE: GS).

Thinking about picking up some shares of "venerable financial institutions" like Lehman Brothers Holdings (NYSE: LEH), Merrill Lynch & Co. (NYSE: MER), Citigroup Inc (NYSE: C) and Washington Mutual Co (NYSE: WM)?

Think again.

As Bill Miller of Legg Mason Value Trust has learned the hard way, just because a stock looks like it's undervalued doesn't mean it won't keep getting more undervalued. Especially when there's the risk of an all-out catastrophe a la Bear Stearns thanks to these companies' incestuous affair with leverage.

Take Lehman in particular, it's trying desperately to raise capital, by any means necessary, but can it go to the multi-trillion hedge fund industry? No. Hedge funds have trillions because they're smart. They know at this point that Lehman is a longshot. So, Lehman must negotiate with smallish foreign countries that are trying to get some good old American power and even there it's getting rejected!

That's just sad.

Yesterday's announcement by Freddie Mac (NYSE: FRE) to cut but not eliminate its dividend payment got me wondering if there were other companies out there with absurdly high dividend yields that hadn't cut their payments. High-dividend yields are an old-fashioned way to look at companies and one that's fallen out of fashion as tech companies plowed their profits into research. But a 10% yield -- hey even a 7% yield -- is something we'd all be happy to find these days.

Traditionally, companies with high-dividend yields were those with low-growth potential, like utilities. Like Freddie, many of the current high-yield companies were created by a falling stock price. And like Freddie, they could always cut the dividend to keep the yield from getting out of whack. But, if they think the stock will rebound, maybe they won't cut it for fear the dividend cut would be yet another thing to drive off investors.

The highest yielding big company I found was Biovail (NYSE: BVF), Canada's biggest drug maker. The company was hit with an SEC complaint that key executives were lying about earnings. The company and the founder just settled a fight over the future direction of the company -- with the founder stepping aside. The stock, at about $10, has been cut in half in the last year. In May the company declared a quarterly dividend of 37.5 cents a share, which gives it a 15% yield at the current price.

Take it Private! is a series looking at one company each week that, in my opinion, has no reason for being public. To find these companies, I screen for the following:

• high insider ownership
• a history of solid profitability
• a paltry Price/Earnings and/or Price/Cash Flow multiple
• a stagnant stock price accompanied by low volume indicating a lack of interest in the stock.

My purpose in highlighting these companies? This screen can be a good way to find deep value stocks, especially companies that may be attractive to a strategic buyer, private equity firm or management-led buyout at a premium to the current share price. However these profiles should not be interpreted as a recommendation to buy a certain stock. Let's take a look at Rex Stores (NASDAQ: RSC), a stock that I've followed with interest since 2004. Rex Stores owns and operates 111 electronics retail stores in 34 states, a business that has struggled in the face of lower-priced competitors from Best Buy (NASDAQ: BBY) to Wal-Mart (NYSE: WMT)

MicrocapTrader made a compelling and difficult to refute argument about the stock's value in this post from April of 2007: "In any event, assigning a proper valuation to RSC's property brings its tangible book value up to ~ $15 per share without even considering its inventory, worth another $6 per share at its carrying value."

And then there's the ethanol.

After seeing the interest in yesterday's Serious Money: Five stable stocks for troubled times, I decided to track the stocks on a quarterly basis to see how they hold up over time (otherwise, what would be the purpose of discussing them in the first place?).

I said that all five have shrewd, conservative management teams and have been in the right place, at the right time -- and prepared. The standard for comparison will be the Standard & Poors 500 Index which closed on June 30, 2008 at 1,280.00. Although my original story was published yesterday, I will be using the second quarter end point for my five stocks as well.

1) Johnson and Johnson (NYSE: JNJ) closed at $64.34 and pays a 2.89% dividend yield.

2) Teva Pharmaceuticals ADR (NASDAQ: TEVA) closed at $45.80 and pays a 1% dividend yield.

3) Chubb Corp (NYSE: CB) closed at $49.01 and pays a 2.64% dividend yield.

I know, I know, with the economy sputtering, why would you ever want to be invested in an apparel company that produces expensive jeans? Let alone have it recommended by a typically short-selling trader like me! But before I tell you the name of this stock that despite the obvious economic problems -- strong oil, weak housing and the dollar, mounting foreclosure, etc -- is sitting right near all-time highs, looking to break out, let's do a quick rundown of its competitors in the apparel retail space.

There's Polo Ralph Lauren Corp (NYSE: RL) and Lululemon Athletica (NASDAQ: LULU), which after substantial runups and crushing drops off their highs, have been trying to find their footing. Then there are steady downtrenders Under Armour Inc (NYSE: UA), American Eagle Outfitters (NYSE: AEO), Pacific Sunwear of California (NASDAQ: PSUN), Liz Claiborne Inc. (NYSE: LIZ) and Bebe Stores (NASDAQ: BEBE). And last but certainly not least, the stock-that's-gone-absolutely-nowhere-for-the-past-six-years-meaning-its-been-useless-for-both-longs-and-shorts The Gap Inc (NYSE: GPS).

Every once in a while I run a stock screen to see if anything passes some very stringent criteria, only to find nothing passes through. Yesterday something did come up: Gramercy Capital Corp. (NYSE: GKK). Here was my criteria on the screen, along with Gramercy's numbers:

• One year sales growth had to be at least 20% (65%)
• Minimum profit margin of 20% (49%)
• Maximum Price-to-sales ratio under 3 (2)
• Stock price between $10 ad $25 ($17)
• Market capitalization under $1 billion ($900 million)

I could have added more criteria because to my pleasant surprise Gramercy is paying over a 14% yield, has a very low trailing P/E of of 3.34 and forward looking guess of 5.7. Furthermore, it has Return on Equity (ROE) Per Share of 29.84% and a Price-to-book of 1.26. So everything is looking good, but is it a value or value trap?

Forget about overwhelmingly random stock market noise and small daily percentage moves exemplified by the likes of all the most popular names such as Yahoo! Inc (Nasdaq: YHOO), Citigroup Inc (NYSE: C), Pfizer Inc (NYSE: PFE), Google Inc (Nasdaq: GOOG) and Apple Inc (Nasdaq: AAPL). Don't be fooled by the all-too-frequent daily commentary-those stocks are really only good for long-term investors and the few truly professional traders out there.

If you're neither, focus more on market inefficiencies because not only are they more predictable, but they're ideal for smaller investors and traders thanks to their illiquidity. Meaning the market offers up these high profit probability opportunities that the big boys can't and won't take advantage of-they're strictly for us little guys.

I'm talking about price moves created by the quirks of the finance industry itself-namely the media circus, stock promoters and hype that influence the great derided microcap market. For example, when a CNBC reporter inadvertently suckers amateurs by pumping a penny stock (good short selling opportunity as the stock is now down 50% in a month) or when a stock promoter is paid to hype a stock (another one down 50%+ in one month since).

It is always interesting to see the changes in short interest, particularly when you are right in the middle of earnings season. It seems the short sellers have gotten a little less confident on the "digital four" of the NASDAQ. In fact, the only one of the four that saw an increase was only a tiny increase.

As you will see below, the major components of the NASDAQ top digital companies saw real short covering ahead of earnings. Keeping conviction against stocks is frequent, but the lessons of eternal pessimism have historically shown to not be a winning strategy.

Microsoft Corp. (NASDAQ: MSFT)
Short Interest Change Avg, Day Vol. Days to Cover
04/15/2008 109,056,265 (7.88%) 48,450,376 2.25
03/31/2008 118,383,897 (3.82%) 57,762,166 2.05

Google Inc. (NASDAQ: GOOG)
Short Interest Change Avg, Day Vol. Days to Cover
04/15/2008 4,905,775 (5.84%) 5,368,787 1.00
03/31/2008 5,210,156 7.07% 6,382,427 1.00

Yahoo! Inc. (NASDAQ: YHOO)
Short Interest Change Avg, Day Vol. Days to Cover
04/15/2008 36,104,797 (12.54%) 22,789,737 1.58
03/31/2008 41,280,401 (17.13%) 25,874,919 1.60

Oracle Corp. (NASDAQ: ORCL)
Short Interest Change Avg, Day Vol. Days to Cover
04/15/2008 42,655,256 2.94% 34,868,017 1.22
03/31/2008 41,436,043 6.57% 51,966,613 1.00

As Oracle's earnings are still a ways out, the need for traders to cover there probably wasn't as critical as it was otherwise.

Jon Ogg is an editor and producer of the "10 Stocks Under $10" weekly newsletter for 247WallSt.com.

"A once in a lifetime super bull market in commodities is underway," note resource experts Mary Anne and Pamela Aden. Here, the advisors look at some favorite commodity stocks in their The Aden Forecast.

"Commodities are in a mega super rise is because of the dramatic changes in the global economy. The rise that started in commodities in 2001 has continued to expand over the years and we believe the upmove is just warming up and it has years to run.

"There are several reasons for this. The weakening dollar and low interest rates have certainly helped push up the whole sector while investment demand grew as an inflation hedge. But the key reason why the commodities are in a mega super rise is because of the dramatic changes in the global economy.